OCCUDO QUANTITATIVE STRATEGIES LP - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
OCCUDO QUANTITATIVE STRATEGIES LP ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$111,260
-36.8%
10,198
-51.2%
0.01%
-7.1%
Q3 2022$176,000
-83.9%
20,887
-84.9%
0.01%
-84.4%
Q2 2022$1,095,000
+98.0%
138,395
+492.4%
0.09%
+95.7%
Q1 2022$553,000
+30.7%
23,360
-2.2%
0.05%
-9.8%
Q3 2021$423,00023,8760.05%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$67,646,43421.00%
COWEN AND COMPANY, LLC 1,657,551$45,781,5583.80%
Kynam Capital Management, LP 975,298$26,937,7313.70%
BVF INC/IL 3,775,900$104,290,3582.91%
RTW INVESTMENTS, LP 5,415,514$149,576,4972.85%
Cormorant Asset Management, LP 1,500,000$41,430,0002.32%
Ghost Tree Capital, LLC 225,000$6,214,5002.05%
683 Capital Management, LLC 814,000$22,482,6801.62%
Perceptive Advisors 1,469,761$40,594,7991.18%
Artia Global Partners LP 112,340$3,102,8311.07%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders